India registered a sustained growth in the Bioeconomy from $44 Bn US in 2019 to 80.1 Bn in 2021: Dr Jitendra Singh
Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh said, India has a target of 300 billion US Dollars in Bioeconomy by 2030.
In a written reply to a question in the Rajya Sabha today, Dr Jitendra Singh said, India registered a sustained growth in the Bioeconomy from $44 Bn US in 2019 to 80.1 Bn in 2021.
Bioeconomy is the production, utilization and conservation of biological resources, including related knowledge, science, technology, and innovation, to provide information, products, processes and services across all economic sectors. The Indian biotech industry is aligned around five major segments: BioPharma, BioAgriculture, BioIndustrial, Bio-energy and the combined segment of BioServices comprising of BioIT, CROs, and Research Services.
Bioeconomy is seen as a means to address societal challenges. For example, the use of biomass or renewable resources in energy production processes, use of green chemicals and materials; biofertilizers, waste reduction etc. may impact and have cascading effects on carbon footprint, food and nutrition, health, and energy independence, and environmental sustainability. New Innovative solutions are expected from Biotech Industry, Research Institutes and the growing Biotech Startup ecosystem.
Disclaimer : This is an official press release by PIB.